Free cash flow generation is erratic, ranging from a negative $133.4M to a positive $105.8M over the past ten quarters, driven by seasonal working capital swings and lumpy capital expenditures that average 15-20% of revenue.
Adecoagro S.A. (AGRO) cash flow statement — 19-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 |
|---|
| Cash from Operations | 284.33M | 284.86M | 328.33M | 434.91M | 370.03M | 348.66M | 257.13M | 322.11M | 218.51M | 237.1M | 255.4M | 153.91M | 133.13M | 102.08M | 67.82M | 56.59M | 26.94M | -86.3M | -52.45M | -68.04M |
| Operating CF Margin % | - | 19.95% | 21.62% | 33.48% | 27.46% | 31.01% | 31.44% | 36.31% | 27.55% | 25.41% | 29.38% | 22.83% | 18.41% | 15.84% | 11.22% | 8.77% | 6.32% | -21.68% | -17.12% | -37.35% |
| Operating CF Growth % | -4.48% | -13.24% | -24.51% | 17.53% | 6.13% | 35.6% | -20.17% | 47.41% | -7.84% | -7.16% | 65.94% | 15.61% | 30.42% | 50.51% | 19.86% | 110.07% | 131.21% | -64.53% | 22.91% | - |
| Net Income | 49.48M | -8.35M | 92.1M | 226.72M | 108.61M | 130.72M | 1.07M | 342K | -23.23M | 14.97M | 14.28M | -4.35M | 11.04M | -27.6M | 13.32M | 57.95M | -44.79M | -275K | -16.43M | 28.63M |
| Depreciation & Amortization | 329.1M | 194.85M | 304.02M | 274.1M | 254.38M | 218.13M | 182.69M | 219.61M | 154.25M | 151.01M | 127.5M | 104.4M | 137.67M | 69.4M | 54.47M | 34.18M | 37.56M | 30.36M | 28.31M | 9.36M |
| Stock-Based Compensation | 3.84M | 0 | 6.68M | 8.58M | 10.23M | 6.41M | 4.32M | 4.73M | 4.73M | 5.55M | 4.8M | 4.4M | 3.87M | 3.8M | 4.14M | 3.68M | 0 | 0 | 0 | 0 |
| Deferred Taxes | 21.5M | -9.25M | -76.5M | 78.67M | 26.76M | 43.84M | 12.32M | 20.82M | -1.02M | -4.99M | 12.9M | -7.95M | 10.54M | -9.28M | -5.44M | 14.66M | -16.26M | 0 | 0 | 0 |
| Other Non-Cash Items | 14.8M | 138.58M | 181.47M | -82.39M | 56.89M | 111.42M | 141.88M | 92.21M | 102.47M | 51.87M | 147.43M | 60.27M | 51.74M | 93.38M | 30.35M | -14.38M | 70.89M | -88.16M | -25.16M | -52.81M |
| Working Capital Changes | -138.6M | -30.98M | -179.45M | -70.79M | -86.83M | -161.84M | -85.16M | -15.6M | -18.68M | 18.7M | -51.5M | -11.57M | -94.7M | -27.63M | -29.02M | -39.51M | 11.04M | 12.27M | -39.18M | -53.22M |
| Change in Receivables | 12.58M | -57.22M | -68.3M | 3.68M | -60.75M | -40.45M | -55.23M | -17.66M | -65.94M | -9.48M | -31M | -2.3M | -38.62M | -35.46M | -39.16M | -15.85M | 3.58M | -30.39M | -28.38M | -18.35M |
| Change in Inventory | -33.21M | 25.83M | -35.77M | -35.8M | 41.75M | -95.22M | -40.45M | -17.04M | -38.57M | -22.1M | -45.98M | -29.43M | -73.05M | -27.97M | -9.62M | -43.03M | 9.43M | 3.44M | -3.29M | -23.16M |
| Change in Payables | -13.74M | -3.05M | -100.35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash from Investing | -1.15B | -951.77M | -231.56M | -111.55M | -299.26M | -175.22M | -121.92M | -248.71M | -174.92M | -188.34M | -122.01M | -133.78M | -313.45M | -161.54M | -300.21M | -140.49M | -111.72M | -73.89M | -157.49M | -246.91M |
| Capital Expenditures | -237.02M | -266.3M | -260.21M | -241.62M | -217.78M | -199.29M | -168.53M | -252.45M | -207.07M | -198.55M | -132.39M | -141.46M | -305.73M | -128.73M | -218.77M | -90.42M | -87.68M | -97.82M | -186.3M | -130.17M |
| CapEx % of Revenue | 14.37% | 18.65% | 17.13% | 18.6% | 16.16% | 17.73% | 20.61% | 28.46% | 26.1% | 21.28% | 15.23% | 20.98% | 42.29% | 19.97% | 36.18% | 14.01% | 20.57% | 24.57% | 60.79% | 71.45% |
| Acquisitions | -981.39M | -668.05M | -16.18M | -3.19M | 11.12M | 10.01M | 10.15M | 683K | 0 | 0 | 3.42M | 3.89M | -54K | 7.91M | 10.21M | -11.62M | -2.4M | 16.43M | 0 | -127.47M |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 42M | 0 | 30.32M | 97.65M | 5.4M | 14.06M | 36.46M | 2.13M | 31.96M | 10.21M | 6.96M | 12.52M | 5.31M | -53.79M | -91.65M | 24.62M | -21.65M | -32.99M | 28.81M | 10.73M |
| Cash from Financing | 971.24M | 834.49M | -274M | -208.74M | -23.57M | -303.13M | -53.92M | -37.86M | -20.85M | 70.19M | -181.68M | 92.41M | 73.29M | 104.67M | 133.51M | 360.79M | 46.55M | 156.05M | 213.2M | 292.35M |
| Debt Issued (Net) | 869.67M | 680.23M | -147.52M | -92.21M | 91.17M | -185.14M | 14.61M | 19.82M | 48.66M | 167.35M | -125.17M | 136.62M | 85M | 155.65M | 167.88M | -27.72M | 79.83M | 86.95M | 37.75M | 118.23M |
| Equity Issued (Net) | 264.44M | 293.52M | -66.89M | -26.24M | -36.84M | -66.46M | -4.37M | -4.26M | -15.72M | -38.37M | -4.77M | -320K | -12.99M | -5.1M | 0 | 421.78M | 0 | 0 | 0 | 0 |
| Dividends Paid | -31.05M | -35M | -35M | -35M | -35M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 945.86K | -10.21M | -66.89M | -26.24M | -36.84M | -66.46M | -4.37M | -4.26M | -15.72M | -38.37M | -4.77M | -320K | -12.99M | -5.1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | -131.82M | -104.27M | -24.6M | -55.29M | -42.9M | -51.53M | -64.16M | -53.42M | -53.79M | -58.79M | -51.74M | -43.89M | 1.28M | -45.87M | -34.37M | -33.27M | -33.28M | 69.1M | 175.45M | 174.12M |
| Net Change in Cash | 121.86M | 171.91M | -128.54M | 109.13M | 30.89M | -136.52M | 46.01M | 16.64M | 4.44M | 110.63M | -40.33M | 85.1M | -118.35M | 13.34M | -111.74M | 260.28M | -4.54M | -18.55M | 22.67M | -35.5M |
| Free Cash Flow | 47.72M | 20.6M | 65M | 191.48M | 139.8M | 135.66M | 80.14M | 56.09M | 2.42M | 34.72M | 120.08M | 2.21M | -187.68M | -124.51M | -233.92M | -97.11M | -62.55M | -143.94M | -238.75M | -198.36M |
| FCF Margin % | 2.89% | 1.44% | 4.28% | 14.74% | 10.37% | 12.07% | 9.8% | 6.32% | 0.3% | 3.72% | 13.81% | 0.33% | -25.96% | -19.31% | -38.68% | -15.05% | -14.67% | -36.16% | -77.9% | -108.88% |
| FCF Growth % | -36.41% | -68.31% | -66.05% | 36.96% | 3.06% | 69.29% | 42.86% | 2220.77% | -93.04% | -71.09% | 5326.03% | 101.18% | -50.73% | 46.77% | -140.89% | -55.24% | 56.54% | 39.71% | -20.36% | - |
| FCF per Share | 0.07 | 0.04 | 0.13 | 0.36 | 0.25 | 0.23 | 0.14 | 0.10 | 0.00 | 0.06 | 0.20 | 0.00 | -0.31 | -0.20 | -0.38 | -0.16 | -0.11 | -0.13 | -0.23 | -0.27 |
| FCF Conversion (FCF/Net Income) | 0.96x | -34.12x | 3.56x | 1.92x | 3.42x | 2.67x | 624.09x | -417.24x | -8.87x | 23.78x | 125.26x | 8.98x | 52.87x | -3.95x | 7.22x | 1.01x | -0.61x | 331.92x | 2.71x | -2.33x |
| Interest Paid | 8.02M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying AGRO stock.
Adecoagro S.A. (AGRO) generated $284.9M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Adecoagro S.A. (AGRO) generated $20.6M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Adecoagro S.A. (AGRO) spent $266.3M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Adecoagro S.A. (AGRO) returned $35.0M to shareholders via cash dividends and spent $10.2M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Earnings quality obscured by non-cash items
Earnings Quality Masked by Non-Cash Adjustments
The stark divergence between net income and operating cash flow, with OCF/NI ratios swinging from -0.06 to 16.22, suggests reported earnings are heavily distorted by non-cash items like biological asset revaluations, making cash flow a far more reliable indicator of operational performance.
The company's operating cash flow consistently dwarfs its net income, a pattern that appears driven by the add-back of significant non-cash depreciation and biological asset adjustments under IAS 41. For instance, in 2026Q2, $125.0M of operating cash flow was generated from just $18.2M of net income, with D&A of $105.9M being a major reconciling item. This indicates that the reported net loss or thin profit is not reflective of the underlying cash-generating ability of the industrial and farming assets, but investors must scrutinize the quality and sustainability of these non-cash adjustments.
Volatile FCF Driven by Seasonal and Acquisition Cycles
Free cash flow exhibits extreme volatility, ranging from a negative $133.4M to a positive $105.8M over the past ten quarters, indicating that FCF generation is highly dependent on seasonal harvest timing and lumpy capital deployment rather than a stable, predictable trajectory.
The FCF margin has swung from -51.0% to 28.3%, a pattern that aligns with the agricultural cycle where Q1 typically sees heavy working capital outflows and capex, while Q4 and Q2 often show strong cash generation. The negative FCF in 2026Q1 (-$89.9M) was exacerbated by a large acquisition outflow of $396.3M, demonstrating how strategic investments can temporarily overwhelm operational cash generation. This volatility makes it challenging to assess a normalized FCF run-rate without adjusting for these cyclical and episodic factors.
Capital Intensity Reflects Industrial Model
Consistent capital expenditure, averaging roughly 15-20% of revenue, underscores the capital-intensive nature of maintaining and upgrading the company's sugar mills and land transformation assets, which is necessary to preserve its low-cost producer advantage.
Capex has remained substantial, ranging from $34.5M to $94.0M per quarter, with the CapEx/Rev ratio spiking to 35.9% in 2024Q1. This level of investment appears to be a mix of maintenance capex for the industrial mills and growth capex for land development and potential expansions. The significant D&A figures, often exceeding $70M per quarter, suggest that a large portion of this spending is required just to replace depreciating assets, indicating high capital intensity that pressures free cash flow conversion.
Working Capital Swings Drive Cash Flow Volatility
Working capital changes are a primary driver of quarterly cash flow volatility, with swings from a -$119.6M use of cash to a +$57.1M source, reflecting the seasonal inventory build-up and collection cycles inherent in the agricultural business model.
The working capital dynamics are highly erratic, with large negative changes (cash outflows) in Q1 periods (e.g., -$119.6M in 2024Q1, -$97.6M in 2026Q1) likely corresponding to pre-harvest inventory and input purchases. Conversely, positive changes in Q4 and Q2 suggest the collection of receivables and sale of inventory. This pattern indicates that Adecoagro's cash flow is heavily influenced by the timing of its agricultural cycle, and the magnitude of these swings can obscure the underlying operational cash generation in any single quarter.
Capital Allocation Prioritizes Growth Over Shareholder Returns
Capital deployment is overwhelmingly directed toward acquisitions and capital expenditures, with the $396.3M acquisition in 2026Q1 dwarfing the modest and inconsistent dividend payments, suggesting a strategy focused on asset accumulation rather than direct shareholder returns.
The company's primary use of cash has been for acquisitions, most notably the $396.3M outflow in 2026Q1 and a $580.1M outflow in 2025Q4, indicating an active land or asset acquisition strategy. Dividend payments are regular but small, typically around $17.5M per quarter when paid, and share repurchases have been minimal and sporadic. This allocation pattern suggests management is reinvesting cash flow into expanding the asset base, particularly in land transformation, rather than returning capital to shareholders, which aligns with the long-term value creation thesis but offers limited near-term cash yield.
Cash Flow Obscured by Biological Assets and FX
The cash flow statement may not fully capture the economic reality due to non-cash biological asset revaluations that flow through net income but not cash, and complex foreign exchange effects that can distort the translation of local currency operations into the USD reporting currency.
A key analytical challenge is that the reported net income, which drives the OCF/NI ratio, is subject to significant non-cash volatility from IAS 41 biological asset accounting. This means the large positive reconciling items between net income and operating cash flow are not necessarily indicative of high-quality earnings but rather accounting adjustments. Furthermore, with operations in Brazil and Argentina but a USD functional currency, foreign exchange translation effects can create mismatches between reported revenues and the actual local currency cash flows, potentially obscuring the true operational performance and cash generation in each geography.